✦ LIBER ✦
Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer: A Network Meta-Analysis with Parametric Survival Models
✍ Scribed by Cope, Shannon; Ouwens, Mario J.N.M.; Jansen, Jeroen P.; Schmid, Peter
- Book ID
- 120061412
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 928 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.